Susquehanna International Group »

Enlivex Therapeutics shares owned by Susquehanna International Group

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Susquehanna International Group from 13F filings

Historical chart of Susquehanna International Group investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Susquehanna International Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Susquehanna International Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $20k 12k 1.58
2023-06-30 $40k 15k 2.63
2023-03-31 $65k 18k 3.64
2022-12-31 $72k 19k 3.82
2022-09-30 $85k 20k 4.19
2022-06-30 $98k 22k 4.45
2022-03-31 $126k 23k 5.61